Drug Trial Radar · NCT06801223
A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection
Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
48
Planned (sponsor's estimate)
Start
Dec 30, 2026
Primary completion
May 5, 2028
Study completion May 20, 2028
Sponsor
- Lead sponsor
- Innoviva Specialty TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- Entasis Therapeutics
- First posted
- Jan 30, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 1 day, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to investigate the use of Sulbactam-Durlobactam (SUL-DUR) in pediatric patients and is being conducted to collect pharmacokinetic (PK) and safety data to enable the identification of appropriate pediatric dosing regimens for patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections
Conditions
- Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Interventions
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours)Drug
25mg/kg SUL and 25mg/kg DUR
Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours)Drug
20mg/kg SUL and 20mg/kg DUR
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours)Drug
25mg/kg SUL and 25mg/kg DUR
Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours)Drug
20mg/kg SUL and 20mg/kg DUR
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assess the pharmacokinetic (PK) parameters for maximum concentration (Cmax) of sulbactam and durlobactamTime frame: Day 1 and Day 3
- Assess the PK parameters for area under the plasma concentration-time curve from 0 to 24 hours (AUC 0-24) of sulbactam and durlobactamTime frame: Day 1 and Day 3
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
UCLA Medical Center
Los Angeles, California · Recruiting
Rady Children's Hospital
San Diego, California · Recruiting
ECU Brody School of Medicine
Greenville, North Carolina · Recruiting
University of Texas Medical Branch at Galveston
Galveston, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.